- Category
- Defining Matters
- Date
- April 20, 2017
- Title
-
Kramer Levin Completes Follow-on Equity Offering for Sorrento Therapeutics Inc.
Kramer Levin represented Cantor Fitzgerald & Co., as the Lead Book-Running Manager, in a shelf takedown for 23,625,084 shares of the common stock of Sorrento Therapeutics Inc., a clinical-stage biopharmaceutical company. The offering included the option for certain underwriters to purchase up to an aggregate of 3,543,763 additional shares.
Related People
-
-
Christopher S. Auguste
-
- Partner
- Chair, Diversity Committee; Co-Chair, Pro Bono Committee; Co-Chair, Equity Capital Markets and Public Companies
- New York
- vcard
-
-
-
Richard E. Farley
-
- Partner
- Chair, Leveraged Finance Group
- New York
- vcard
-
